Department of Psychology & Center for Neuroscience Research, University at Albany, Albany, NY, USA.
J Neuroendocrinol. 2021 Mar;33(3):e12962. doi: 10.1111/jne.12962.
The synthetic progestin 17-α-hydroxyprogesterone caproate (17-OHPC) is commonly prescribed to pregnant women with a history of preterm delivery, despite little evidence of efficacy. The timing of 17-OHPC administration coincides with fetal mesocortical dopamine pathway development, yet the potential effects on cortical development and cognition are almost unknown. In rodent models, exposure to 17-OHPC significantly increased dopaminergic innervation of the medial prefrontal cortex (mPFC), an aberrant pattern of connectivity that may underlie deficits in cognitive flexibility observed in adulthood. In the present study, tyrosine hydroxylase (TH) immunoreactivity was used to determine whether 17-OHPC altered dopaminergic innervation of the mPFC during a neonatal period of synaptogenesis in males and females. Although there were no differences in the amount of TH-immunoreactive (-IR) fibres, there was a sex difference in TH-IR fibre distribution in deep layers of the prelimbic area (PL) mPFC; males had a narrower pattern of dopaminergic innervation than females. 17-OHPC exposure abolished these sex-specific patterns, such that 17-OHPC females had a narrower pattern in the PL than control females. In the infralimbic mPFC (IL), 17-OHPC males had a broader pattern of distribution of TH-immunoreactivity than control males with no differences in the amount of TH-IR fibres. 17-OHPC also created a sex difference in which males had a lower TH-IR fibre density than females. We also examined microglia, brain macrophages that play a key role in sculpting dopaminergic axon outgrowth in development, using phenotype as an indirect measure of microglial activity. Females had a greater number of reactive stout microglia compared to males in the PL, and males had more active round microglia than females in the IL. 17-OHPC treatment abolished the sex differences in both regions. These findings demonstrate that developmental exposure to 17-OHPC can exert differential effects in males and females and may diminish sex differences in cortical maturation.
合成孕激素 17-α-羟孕酮己酸酯(17-OHPC)常用于有早产史的孕妇,但几乎没有疗效证据。17-OHPC 给药的时间与胎儿中脑边缘多巴胺通路的发育相吻合,但皮质发育和认知的潜在影响几乎未知。在啮齿动物模型中,暴露于 17-OHPC 显著增加了内侧前额叶皮质(mPFC)的多巴胺能神经支配,这种连接模式的异常可能是成年后认知灵活性缺陷的基础。在本研究中,使用酪氨酸羟化酶(TH)免疫反应来确定 17-OHPC 是否在雄性和雌性的突触发生新生儿期改变 mPFC 的多巴胺能神经支配。尽管 TH-免疫反应性(TH-IR)纤维的数量没有差异,但在 mPFC 的前扣带回区(PL)的深层中存在 TH-IR 纤维分布的性别差异;雄性的多巴胺能神经支配模式比雌性更窄。17-OHPC 暴露消除了这些性别特异性模式,使得 17-OHPC 雌性在 PL 中的模式比对照雌性更窄。在 mPFC 的下边缘区(IL)中,17-OHPC 雄性的 TH-免疫反应性分布模式比对照雄性更宽,而 TH-IR 纤维的数量没有差异。17-OHPC 还导致了一种性别差异,即雄性的 TH-IR 纤维密度低于雌性。我们还使用表型作为大脑巨噬细胞(在发育中对多巴胺能轴突生长起着关键作用的脑巨噬细胞)的间接测量,检查了微胶质细胞。在 PL 中,雌性的反应性粗壮微胶质细胞数量多于雄性,而在 IL 中,雄性的活性圆形微胶质细胞多于雌性。17-OHPC 处理消除了这两个区域的性别差异。这些发现表明,发育过程中暴露于 17-OHPC 可能会对雄性和雌性产生不同的影响,并可能减少皮质成熟过程中的性别差异。